Filing Details

Accession Number:
0001209191-16-137607
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-17 17:37:21
Reporting Period:
2016-08-16
Filing Date:
2016-08-17
Accepted Time:
2016-08-17 17:37:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
906709 Nektar Therapeutics NKTR Pharmaceutical Preparations (2834) 943134940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1480111 K Stephen Doberstein C/O Nektar Therapeutics
455 Mission Bay Boulevard South
San Francisco CA 94158
Svp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-08-16 1,336 $17.56 18,935 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $17.47 to $17.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  2. The total holdings include the remaining portion of the 10,500 shares of restricted stock units ("RSUs") that were previously reported in Table II for the reporting person and which are being reclassified to Table I. These RSUs were granted on December 15, 2015, are convertible on a one-for-one basis into shares of Common Stock of the Company, and vest on a quarterly pro-rata basis over a period of three (3) years from the date of grant.